Clinical Trials for Amylyx Pharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Amylyx Pharmaceuticals

Clinical Trials (5)

NCT06747468
Avexitide for Treatment of Post-Bariatric Hypoglycemia
PHASE3Recruiting
75 participants
Started: Apr 29, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor21 locations
NCT06665165
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
PHASE1Recruiting
48 participants
Started: Apr 7, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor14 locations
NCT06122662
AMX0035 and Progressive Supranuclear Palsy
PHASE2/PHASE3Active, not recruiting
110 participants
Started: Dec 21, 2023 · Completed: Nov 30, 2029
4 conditions1 sponsor62 locations
NCT05676034
AMX0035 in Adult Patients With Wolfram Syndrome
PHASE2Active, not recruiting
12 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05021536
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
PHASE3Active, not recruiting
664 participants
Started: Oct 28, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor69 locations